Navigation Links
Pradaxa Side Effect Problems Continue, as New Report Finds Pradaxa Bleeding More Likely to Result in Death, Bernstein Liebhard LLP Reports
Date:1/19/2013

New York, NY (PRWEB) January 19, 2013

Pradaxa side effects continue to be reported to the U.S. Food & Drug Administration (FDA), Bernstein Liebhard LLP reports. According to the latest QuarterWatch Report issued by the Institute for Safe Medicine Practices (ISMP), an analysis of hemorrhage cases reported to the FDA during the second quarter of 2012 found that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding. The estimate of higher odds for a fatal outcome persisted after adjusting for differences in patient age, gender, and report source, the ISMP said.*

“We continue to hear from Pradaxa patients who experienced frightening episodes of bleeding while using this blood thinner. Considering that there is no readily available antidote for Pradaxa bleeding, we are not surprised by the ISMP’s findings,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The firm is currently offering free Pradaxa lawsuit evaluations to individuals who suffered life-threatening hemorrhaging, allegedly due to Pradaxa.

Pradaxa Lawsuits
Pradaxa, which is used to prevent strokes in people with a heart-rhythm disorder known as atrial fibrillation, was approved by the U.S. Food & Drug Administration (FDA) in October 2010. According to a recent report from Bloomberg.com, regulators in several countries have issued Pradaxa safety alerts since the drug was first brought to market.** Most recently, the FDA released a Drug Safety Communication announcing a new contraindication was being added to the Pradaxa label to warn against its use in patients with mechanical heart valves.***

At least 176 Pradaxa lawsuits have been consolidated in a multidistrict litigation now underway in U.S. District Court, Southern District of Illinois. The complaints allege plaintiffs suffered serious, life-threatening episodes of Pradaxa bleeding, and that Boehringer Ingelheim sold the blood thinner despite knowing it could cause fatal bleeding in some patients. According to court documents, the Pradaxa litigation’s first trial has been scheduled for August 2014. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

Victims of serious Pradaxa bleeding may be eligible to collect compensation for their medical bills, lost wages, pain and suffering and more. To learn more, please visit the firm’s Pradaxa lawsuit website, or call 1-877-779-1414 to speak with an attorney today.

*ismp.org/quarterwatch/pdfs/2012Q2.pdf
**bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html
***fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm333209.htm

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/pradaxa-side-effects/pradaxa-lawsuits/prweb10340277.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Approval of Safer Alternative to Pradaxa Delayed by FDA
2. Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
3. FDA: Dont Use Pradaxa Blood Thinner in Patients With Artificial Heart Valves
4. Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports
5. Carey Danis & Lowe Issues an Update on the Pradaxa Multi-District Litigation No. 2385
6. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
7. DrugRisk Announces New Pradaxa Health Warning From Australia
8. 176 Pradaxa Lawsuits Now Pending in Federal Litigation, Discovery Well Underway, Bernstein Liebhard LLP Reports
9. Young girls more likely to report side effects after HPV vaccine
10. Preteens More Likely to Report HPV Vaccine Side Effects
11. In children born with severe heart defect, surgical management has little effect on neuro outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , ... January 19, 2017 , ... ... a medical capacity this year. Drs. Alexander Paziotopoulos, Andrew Petersen and Trish Henrie-Barrus ... condensed version of the clinic’s leading recovery program. , “We know it’s ...
(Date:1/19/2017)... ... January 19, 2017 , ... Bio-Optronics Inc. is ... modern CTMS workflow designed to seamlessly integrate and streamline the way researchers prepare ... single page, maximizing usability and improving efficiency significantly for users – a first ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... panel system. , The Tranquility privacy panel system was designed to deliver ... Tranquility panels help reduce noise and provide the visual privacy required to maintain ...
(Date:1/19/2017)... ... 19, 2017 , ... Rountree Brady Insurance Agency, a Savannah ... eastern Georgia, is embarking on a charity effort to raise awareness and gather ... every year than anything else, yet risk factors associated with heart disease are ...
(Date:1/19/2017)... ... 2017 , ... Attorney Robert “RC” Pate , founder of The Law ... Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric cancers. ... the effect of the critical funding gap for research into pediatric cancer research. From ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... January 18, 2017 , , Marks E-QURE ... distribution agreement, following similar agreements in Israel ... Wound care is $2 5 billion ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of ... Médica Equipos Médicos S.A.S. (TeckMedica) in Colombia for the ...
(Date:1/19/2017)... 18, 2017   Synthetic Biologics, Inc. ... therapeutics designed to preserve the microbiome to protect ... plans to initiate a Phase 2b/3 adaptive pivotal ... lovastatin lactone designed to reduce methane production by ... gut to treat the underlying cause of irritable ...
(Date:1/18/2017)... PAUL, Minn. , Jan. 18, 2017 /PRNewswire-USNewswire/ ... developer of medical devices using neuroblocking technology to ... today announced the pricing of an underwritten public ... million, prior to deducting underwriting discounts and commissions ... The offering is comprised of Class A Units, ...
Breaking Medicine Technology: